ALMANAC

ALMANAC is a major breast cancer trial. The acronym stands for "Axillary Lymphatic Mapping Against Nodal Axillary Clearance." This major randomized trial performed in several centres in the UK produced clear evidence that sentinel node biopsy (SNB), used to stage axillary spread of disease, can be used with low failed localization and false negative rates, provided both radioisotope and blue dye are used to locate the sentinel nodes.[1]

This article is about the clinical trial. For other uses, see Almanac (disambiguation).

References
  1. Hiram S Cody (2003). Sentinel Lymph Node Biopsy. Informa Health Care. p. 237. ISBN 1-84184-034-3.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.